GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

For years, Carbios was one of the most visible examples of France’s industrial biotech ambitions in the circular economy. Founded in 2011 and based near Clermont-Ferrand, the company built its story ...